www.MarketResearchReports.com

Competitor Analysis: TNF

Antibodies 2015 - Biosimilars and Biosuperiors of

Humira, Remicade and

Enbrel

Category : Biotechnology

All logos and Images mentioned on this slide belong to their respective owners.

www.MarketResearchReports.com

Introduction to Report

Launch Date: March 22, 2015

Number of Pages: 107

Geography Coverage: Global

Available Format: PDF

Price For Single User License: USD 577

Price For Site User License: USD 1,154

Price For Global User License: USD 1,731

Delivery Time: Within 24 Hours (During Working Days)

www.MarketResearchReports.com

About the Report

The present Competitive Intelligence report about TNF Antibodies 2015– Biosimilars and Biosuperiors of Humira, Remicade and Enbrel provides a competitor evaluation in the field of recombinant antibodies targeting tumor necrosis factor (TNF) alpha or its receptor used to treat various inflammatory and autoimmune diseases as of March 2015.

www.MarketResearchReports.com

Key Highlights:

The five branded anti-TNF antibodies Humira, Remicade, Enbrel, Simponi and Cimzia together achieved global sales of US$ 34.4 bln (+12.9%) in the year 2014.

While the first biosimilars of Humira, Remicade and Enbrel are already marketed in less regulated countries such as India and China, it is only in February of 2015 that a biosimilar TNF antibody has been launched in the European Union.

The Marketing Authorization Applications of further two biosimilar TNF antibodies have been just been submitted to the European Medicines Agency and the clinical pipeline of is rather full.

The report includes a compilation of currently active R&D projects of TNF targeting antibodies for treatment of inflammatory and autoimmune diseases.

www.MarketResearchReports.com

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

www.MarketResearchReports.com

The report includes format providing information on: Drug Codes,

Target / Mechanism of Action,

Class of Compound,

Company

Product Category,

Indication,

R&D Stage and

additional comments with a hyperlink leading to the source of information.

www.MarketResearchReports.com

Report Coverage:

1. TNF Antibodies 2015 – Biosimilars and Biosuperiors of Humira

2. Remicade and Enbrel

3. Marketed TNF Antibodies

4. Biosuperior / Biobetter TNF Antibodies

5. Biosimilar TNF Antibodies

6. Corporate TNF Antibody Biosimilar & Biosuperior Pipelines

For more details regarding Report coverage see the last slide

www.MarketResearchReports.com

Custom Research: Are you an industry professional, entrepreneur,

venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.

For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center

For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter

www.MarketResearchReports.com

How To Buy This Report?

Visit following URL to see Table of Content and purchase this publication:

http://mrr.cm/4Yv

About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.

Contact : Amitava SenEmail : info@marketresearchreports.comPhone: +1 302-703-7787 (USA) +91-8762746600 (India)